Quick Answer
CytoDyn Inc. reported Net Income of $3.75 million for fiscal year 2025.
CytoDyn Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $3.75M | +107.5% |
| 2024 | -$49.84M | +37.6% |
| 2023 | -$79.82M | +62.1% |
| 2022 | -$210.82M | -19.5% |
| 2021 | -$176.47M | -26.1% |
| 2020 | -$139.94M | -149.1% |
| 2019 | -$56.19M | -12.0% |
| 2018 | -$50.15M | -94.7% |
| 2017 | -$25.76M | -0.2% |
| 2016 | -$25.70M | -2.5% |
| 2015 | -$25.09M | -101.8% |
| 2014 | -$12.43M | -29.9% |
| 2013 | -$9.57M | -28.0% |
| 2012 | -$7.47M | -100.9% |
| 2011 | -$3.72M | -10.7% |
| 2010 | -$3.36M | -157.3% |
| 2009 | -$1.31M | -9.4% |
| 2008 | -$1.19M | +54.3% |
| 2007 | -$2.61M | -27.1% |
| 2006 | -$2.05M | -164.3% |
| 2005 | -$777.1K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$22.61M | -374.1% | -308.1% |
| August 31, 2025 | -$5.54M | -128.8% | -16.4% |
| February 28, 2025 | -$4.76M | +60.1% | +0.2% |
| November 30, 2024 | -$4.77M | +50.1% | -124.8% |
| August 31, 2024 | $19.23M | +266.2% | +261.3% |
| February 29, 2024 | -$11.92M | +13.0% | -24.6% |
| November 30, 2023 | -$9.56M | +63.9% | +17.4% |
| August 31, 2023 | -$11.57M | +44.9% | +15.6% |
- CytoDyn Inc. showed an increase of +107.5% in Net Income compared to the prior fiscal year.
- Over the 2005–2025 period, CytoDyn Inc.’s net income has grown by 581.9% (from -$777.1 thousand to $3.75 million).
- The most recent figure is from CytoDyn Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: